The FDA chief has indicated he’s interested in altering the warning on hormone therapies with estrogen. Experts say it’s complicated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback